Sig Brokerage, LP Vertex Pharmaceuticals Inc Transaction History
Sig Brokerage, LP
- $1.99 Trillion
- Q1 2025
A detailed history of Sig Brokerage, LP transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Sig Brokerage, LP holds 1,120 shares of VRTX stock, worth $419,395. This represents 0.03% of its overall portfolio holdings.
Number of Shares
1,120
Previous 1,938
42.21%
Holding current value
$419,395
Previous $780 Million
30.42%
% of portfolio
0.03%
Previous 0.04%
Shares
2 transactions
Others Institutions Holding VRTX
# of Institutions
1,813Shares Held
232MCall Options Held
1.51MPut Options Held
1.09M-
Capital World Investors Los Angeles, CA28.5MShares$10.7 Billion2.34% of portfolio
-
Vanguard Group Inc Valley Forge, PA24MShares$8.98 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$7.98 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA14.5MShares$5.44 Billion1.6% of portfolio
-
State Street Corp Boston, MA11.8MShares$4.41 Billion0.24% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $96.1B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...